Table 1.
In the entire sample |
Among respondents with lifetime SAD |
Among respondents with lifetime SAD |
Among cases that obtained lifetime SAD treatmenta |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
% of lifetime SAD |
% of obtaining treatmenta |
% of perceived treatment as helpfulb |
% of perceived treatment as helpfulb |
|||||||||
n | % | (SE) | n | % | (SE) | n | % | (SE) | n | % | (SE) | |
|
|
|
|
|||||||||
Low and Middle Income Countries | ||||||||||||
Colombia | 4426 | 5.0 | (0.5) | 219 | 13.9 | (3.3) | 219 | 6.8 | (2.4) | 31 | 49.0 | (12.9) |
Iraq | 4332 | 0.8 | (0.2) | 35 | 22.7 | (11.1) | 35 | 21.1 | (10.9) | 6 | 92.8 | (7.9) |
Peru | 3930 | 2.6 | (0.3) | 95 | 18.9 | (4.2) | 95 | 7.5 | (2.7) | 18 | 39.7 | (11.1) |
Shenzhen, PRC | 7132 | 0.9 | (0.2) | 66 | 18.4 | (7.1) | 66 | 12.1 | (6.0) | 8 | 65.8 | (20.4) |
Sao Paulo, Brazil | 5037 | 5.6 | (0.4) | 256 | 21.2 | (2.9) | 256 | 13.7 | (3.3) | 51 | 64.6 | (10.9) |
Bulgaria | 6826 | 0.9 | (0.2) | 56 | 12.0 | (3.5) | 56 | 4.1 | (3.1) | 7 | 34.4 | (18.6) |
Lebanon | 2857 | 1.9 | (0.4) | 52 | 5.7 | (3.5) | 52 | 2.8 | (2.7) | 3 | 48.7 | (31.5) |
Medellin, Colombia | 3261 | 4.6 | (0.5) | 137 | 10.5 | (3.0) | 137 | 6.1 | (2.4) | 18 | 58.1 | (15.0) |
Mexico | 5782 | 2.9 | (0.2) | 203 | 13.5 | (3.2) | 203 | 9.8 | (2.8) | 27 | 72.9 | (9.9) |
Romania | 2357 | 1.3 | (0.3) | 29 | 19.5 | (7.7) | 29 | 17.1 | (7.7) | 5 | 87.6 | (12.1) |
High Income Countries | ||||||||||||
Argentina | 3927 | 2.6 | (0.3) | 111 | 31.8 | (5.0) | 111 | 18.2 | (3.4) | 40 | 57.2 | (11.7) |
Australia | 8463 | 8.5 | (0.4) | 740 | 40.7 | (2.5) | 740 | 27.3 | (2.2) | 302 | 67.0 | (3.5) |
Belgium | 1043 | 2.1 | (0.5) | 37 | 15.7 | (5.6) | 37 | 13.2 | (5.0) | 11 | 83.6 | (8.4) |
France | 1436 | 4.7 | (0.7) | 96 | 21.9 | (6.2) | 96 | 3.6 | (1.6) | 28 | 16.5 | (7.3) |
Germany | 1323 | 2.9 | (0.5) | 68 | 23.2 | (5.2) | 68 | 12.3 | (3.9) | 26 | 52.8 | (10.4) |
Italy | 1779 | 2.1 | (0.3) | 73 | 18.0 | (6.3) | 73 | 9.1 | (4.0) | 12 | 50.4 | (19.9) |
Japan | 4129 | 1.4 | (0.2) | 53 | 16.4 | (6.8) | 53 | 11.5 | (4.9) | 7 | 70.5 | (22.7) |
Murcia, Spain | 2621 | 1.7 | (0.2) | 43 | 31.7 | (10.3) | 43 | 29.8 | (10.3) | 15 | 94.1 | (4.9) |
Netherlands | 1094 | 2.4 | (0.5) | 59 | 32.5 | (6.5) | 59 | 24.1 | (6.7) | 19 | 74.0 | (7.8) |
New Zealand | 12790 | 9.5 | (0.3) | 1283 | 22.8 | (1.5) | 1283 | 15.5 | (1.1) | 278 | 67.9 | (3.4) |
Northern Ireland | 4340 | 6.0 | (0.4) | 283 | 32.5 | (3.2) | 283 | 21.7 | (2.6) | 88 | 66.7 | (6.0) |
Poland | 10081 | 1.4 | (0.1) | 144 | 19.4 | (2.8) | 144 | 14.0 | (2.4) | 28 | 72.3 | (7.2) |
Portugal | 3849 | 4.7 | (0.5) | 188 | 22.6 | (3.2) | 188 | 13.4 | (2.5) | 42 | 59.1 | (8.2) |
Spain | 2121 | 1.3 | (0.3) | 53 | 31.5 | (5.9) | 53 | 23.0 | (5.5) | 17 | 73.0 | (8.6) |
US | 9282 | 12.1 | (0.4) | 1143 | 18.0 | (1.1) | 1143 | 12.3 | (1.1) | 212 | 68.2 | (3.0) |
Saudi Arabia | 3638 | 5.5 | (0.6) | 164 | 11.6 | (3.5) | 164 | 4.0 | (1.5) | 23 | 34.1 | (13.0) |
All Low and Middle Income Countries | 45940 | 2.5 | (0.1) | 1148 | 15.8 | (1.3) | 1148 | 9.5 | (1.2) | 174 | 60.4 | (5.1) |
All High Income Countries | 71916 | 5.9 | (0.1) | 4538 | 24.8 | (0.8) | 4538 | 16.3 | (0.6) | 1148 | 65.9 | (1.7) |
All Countries | 117856 | 4.6 | (0.1) | 5686 | 22.8 | (0.7) | 5686 | 14.9 | (0.6) | 1322 | 65.1 | (1.6) |
χ2 Test on | DF | χ2 | P-value | DF | χ2 | P-value | DF | χ2 | P-value | DF | χ2 | P-value |
|
|
|
|
|||||||||
Low and Middle Income Countries | 9 | 244.5 | <.0001* | 9 | 12.7 | 0.175 | 9 | 11.6 | 0.235 | 9 | 12.5 | 0.188 |
High Income Countries | 15 | 1400.9 | <.0001* | 15 | 108.6 | <.0001* | 15 | 90.8 | <.0001* | 15 | 38.8 | 0.001* |
All Countries | 25 | 1956.2 | <.0001* | 25 | 144.2 | <.0001* | 25 | 119.9 | <.0001* | 25 | 53.5 | 0.001* |
Low and Middle vs. High | 1 | 398.0 | <.0001* | 1 | 26.9 | <.0001* | 1 | 17.4 | <.0001* | 1 | 1.1 | 0.298 |
Abbreviations: SE, standard error; PRC, People’s Republic of China
Cases are based on three conditions: (i) Respondents obtained SAD treatment; (ii) Year of first SAD treatment was 1990 or later; and (iii) Age at onset was the year of first SAD treatment or earlier.
Cases are based on four conditions: (i) Respondents obtained SAD treatment; (ii) Year of first SAD treatment was 1990 or later; (iii) Age at onset was the year of first SAD treatment or earlier; and (iv) Respondents obtained helpful treatment.